CHIP-<i>JAK2V617F</i>, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties-Reference-Cited by-同舟云学术

CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties

Published:2024-02-13 Issue:3 Volume:8 Page:681-682
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Hasselbalch Hans Carl¹²^ORCID,Kristiansen Marie Hvelplund¹³^ORCID,Kjær Lasse²^ORCID,Skov Vibe²^ORCID,Larsen Morten Kranker¹²^ORCID,Ellervik Christina¹⁴⁵^ORCID,Wienecke Troels¹³^ORCID

Affiliation:

1. 1Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

2. 2Department of Hematology, Zealand University Hospital, Roskilde, Denmark

3. 3Department of Neurology, Zealand University Hospital, Roskilde, Denmark

4. 4Department of Data and Data Support, Region Zealand, Sorø, Denmark

5. 5Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/8/3/681/2210993/blooda_adv-2023-012190-c-main.pdf

Reference9 articles.

1. JAK2V617F and ischemic stroke: CHIP or CMD-NBV?;Barosi;Blood Adv,2023

2. JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study;Kristiansen;Blood Adv,2023

3. Clonal hematopoiesis and atherosclerosis;Cassinat;N Engl J Med,2017

4. Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population;Cordua;Blood,2019

5. Early detection of myeloproliferative neoplasms in a Danish general population study;Cordua;Leukemia,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP;Molecular Diagnosis & Therapy;2024-08-20

2. Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis;Life;2024-04-17